Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D2.165 - Geographic Disparities in Air Pollution and Th2-Mediated Airway Inflammation in Pediatric Asthma: A Cross-Sectional Study from Mexico City
D2.167 - Impact of body mass index on oscillometry parameters in children with respiratory symptoms
D2.168 - Impact of type two inflammation inflamation suppression on polyp burden in patients with nasal polyposis and concomitant asthma a comparative evaluation of biologic therapies
D2.171 - Clinical and demographic characteristics associated with a classification as difficult-to-treat asthma: data from the EPI-ASTHMA study
D2.172 - Effectiveness of Mepolizumab in patients with severe asthma and allergic rhinitis: Real-World Evidence from the TYREX Study
D2.173 - Real-World Evidence From the TYREX Study on the effectiveness of Mepolizumab in patients with severe asthma and clinically relevant aeroallergen sensitization
D2.174 - Association Between Environmental Conditions and Mold Sensitization in Children with Allergic Rhinitis and Asthma
D2.175 - Five-Year Real-World Outcomes of Mepolizumab Treatment in Severe Eosinophilic Asthma
D2.176 - Comparison of different treatment strategies for allergic rhinitis in children and their impact on bronchial asthma
D2.179 - Chronic cough triggered by industrialised milk and wheat products
D2.217 - Structured Follow-Up Intervals Enhance Adherence to Sublingual Immunotherapy in Patients with Allergic Rhinitis: Real-World Evidence from a Stepwise Approach
D2.218 - Effectiveness of the 300IR house dust mite sublingual tablet according to the patients’ sensitisation and allergy profile in the real-world, non-interventional VORAN study
D2.222 - A real-world observational study following the first year of SQ grass or SQ tree SLIT-tablet treatment to evaluate persistence and adherence in routine clinical practice among general practitioners in Norway
D2.226 - Evaluation of the Immunogenicity and Stability of an Aluminum-Adsorbed Allergen Immunotherapy Using Specific IgG Titration in a Murine Model
D2.228 - Effectiveness and Safety of Subcutaneous Immunotherapy for Patients Allergic to Either Cat Dander or Dermatophagoides/Cat Dander: Real World Data
D2.214 - TAPAS – non-inferiority of clinical effectiveness in children compared to adults: 3-year interim results of a long-term NIS
D2.215 - A Prospective Long-Term Cohort Study with Seasonal Allergic Rhinitis (TAPAS) with MATAs in tree- and grass-allergic patients
D2.220 - US Regional Difference in Allergen Immunotherapy Prescription Patterns: Focus on the South
D2.221 - Exploring the effect of HDM SLIT-tablets on atopic dermatitis prescriptions in patients with pre-existing atopic dermatitis: Results from the Real-world Evidence of house dust Mite Immunotherapy Tablets (REMIT) study
D2.227 - US Regional Difference in Allergen Immunotherapy Prescription Patterns: Focus on Puerto Rico
Download the app
The congress at your fingertips
Available on
Download